Goutam Dey
Goutam Dey
Post Doctoral Fellow, Cleveland Clinic, Lerner Research Institute, Cleveland, Ohio, USA
Verified email at ccf.org - Homepage
Title
Cited by
Cited by
Year
Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
R Bharti, G Dey, M Mandal
Cancer letters 375 (1), 51-61, 2016
1602016
Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma
S Das, KK Dey, G Dey, I Pal, A Majumder, S MaitiChoudhury, M Mandal
PLoS One 7 (10), e46641, 2012
1282012
Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform
H Choudhury, B Gorain, S Karmakar, E Biswas, G Dey, R Barik, M Mandal, ...
International journal of pharmaceutics 460 (1-2), 131-143, 2014
1222014
Marine lipopeptide Iturin A inhibits Akt mediated GSK3β and FoxO3a signaling and triggers apoptosis in breast cancer
G Dey, R Bharti, G Dhanarajan, S Das, KK Dey, BNP Kumar, R Sen, ...
Scientific reports 5 (1), 1-14, 2015
722015
Insights into molecular therapy of glioma: current challenges and next generation blueprint
Y Rajesh, I Pal, P Banik, S Chakraborty, SA Borkar, G Dey, A Mukherjee, ...
Acta Pharmacologica Sinica 38 (5), 591-613, 2017
612017
Overcoming Akt induced therapeutic resistance in breast cancer through siRNA and thymoquinone encapsulated multilamellar gold niosomes
S Rajput, N Puvvada, BNP Kumar, S Sarkar, S Konar, R Bharti, G Dey, ...
Molecular pharmaceutics 12 (12), 4214-4225, 2015
522015
Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy
I Banerjee, K De, D Mukherjee, G Dey, S Chattopadhyay, M Mukherjee, ...
Acta biomaterialia 38, 69-81, 2016
492016
Microbial amphiphiles: a class of promising new-generation anticancer agents
G Dey, R Bharti, R Sen, M Mandal
Drug Discovery Today 20 (1), 136-146, 2015
462015
Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy
R Bharti, G Dey, I Banerjee, KK Dey, S Parida, BNP Kumar, CK Das, I Pal, ...
Cancer letters 388, 292-302, 2017
432017
Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer
R Bharti, G Dey, PK Ojha, S Rajput, SK Jaganathan, R Sen, M Mandal
Oncogene 35 (30), 3965-3975, 2016
352016
Dietary flavone chrysin (5, 7-dihydroxyflavone ChR) functionalized highly-stable metal nanoformulations for improved anticancer applications
G Sathishkumar, R Bharti, PK Jha, M Selvakumar, G Dey, R Jha, ...
RSC advances 5 (109), 89869-89878, 2015
352015
Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo
A Parekh, S Das, S Parida, CK Das, D Dutta, SK Mallick, PH Wu, ...
Oncogene 37 (33), 4546-4561, 2018
332018
Tailor-made temperature-sensitive micelle for targeted and on-demand release of anticancer drugs
S Panja, G Dey, R Bharti, K Kumari, TK Maiti, M Mandal, S Chattopadhyay
ACS applied materials & interfaces 8 (19), 12063-12074, 2016
332016
Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor
TK Shaw, D Mandal, G Dey, MM Pal, P Paul, S Chakraborty, KA Ali, ...
Drug delivery 24 (1), 346-357, 2017
312017
Therapeutic implication of ‘Iturin A’ for targeting MD-2/TLR4 complex to overcome angiogenesis and invasion
Goutam Dey, Rashmi Bharti, Probir Kumar Ojha, Ipsita Pal, Y. Rajesh ...
Cellular Signalling, 2017
222017
Prevention of epithelial to mesenchymal transition in colorectal carcinoma by regulation of the E-cadherin-β-catenin-vinculin axis
I Pal, Y Rajesh, P Banik, G Dey, KK Dey, R Bharti, D Naskar, ...
Cancer letters 452, 254-263, 2019
212019
Metal ion ornamented ultrafast light-sensitive nanogel for potential in vivo cancer therapy
S Panja, G Dey, R Bharti, P Mandal, M Mandal, S Chattopadhyay
Chemistry of Materials 28 (23), 8598-8610, 2016
202016
Sequential release of drugs from hollow manganese ferrite nanocarriers for breast cancer therapy
BNP Kumar, N Puvvada, S Rajput, S Sarkar, SK Das, L Emdad, D Sarkar, ...
Journal of Materials Chemistry B 3 (1), 90-101, 2015
202015
S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway
KK Dey, R Bharti, G Dey, I Pal, Y Rajesh, S Chavan, S Das, CK Das, ...
Cancer gene therapy 23 (11), 382-391, 2016
182016
Resensitization of akt induced docetaxel resistance in breast cancer by ‘Iturin A’a lipopeptide molecule from marine bacteria bacillus megaterium
G Dey, R Bharti, AK Das, R Sen, M Mandal
Scientific reports 7 (1), 1-11, 2017
172017
The system can't perform the operation now. Try again later.
Articles 1–20